chr7-44111058-G-A
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PVS1_ModeratePM2PP5_Moderate
The NM_001129.5(AEBP1):c.1630+1G>A variant causes a splice donor change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000124 in 1,607,640 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Pathogenic (★).
Frequency
Consequence
NM_001129.5 splice_donor
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AEBP1 | NM_001129.5 | c.1630+1G>A | splice_donor_variant | ENST00000223357.8 | NP_001120.3 | |||
AEBP1 | XM_011515162.2 | c.1552+1G>A | splice_donor_variant | XP_011513464.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
AEBP1 | ENST00000223357.8 | c.1630+1G>A | splice_donor_variant | 1 | NM_001129.5 | ENSP00000223357 | P1 | |||
AEBP1 | ENST00000450684.2 | c.260G>A | p.Arg87His | missense_variant | 1/8 | 2 | ENSP00000398878 | |||
AEBP1 | ENST00000434445.1 | c.*101+1G>A | splice_donor_variant, NMD_transcript_variant | 5 | ENSP00000397241 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152202Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000366 AC: 9AN: 245638Hom.: 0 AF XY: 0.0000377 AC XY: 5AN XY: 132686
GnomAD4 exome AF: 0.0000117 AC: 17AN: 1455320Hom.: 0 Cov.: 33 AF XY: 0.0000124 AC XY: 9AN XY: 723166
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152320Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74482
ClinVar
Submissions by phenotype
Ehlers-Danlos syndrome, classic-like, 2 Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | May 30, 2018 | - - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jun 17, 2023 | This variant is present in population databases (rs369016031, gnomAD 0.01%). For these reasons, this variant has been classified as Pathogenic. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. ClinVar contains an entry for this variant (Variation ID: 545021). Disruption of this splice site has been observed in individual(s) with clinical features of AEBP1-related conditions (PMID: 27023906). It has also been observed to segregate with disease in related individuals. This sequence change affects a donor splice site in intron 13 of the AEBP1 gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in AEBP1 are known to be pathogenic (PMID: 29606302). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at